Latest Articles freerepublic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freerepublic.com Daily Mail and Mail on Sunday newspapers.
Matt Miller / Sara Moser
Steven J. Lawrence, MD, a professor of medicine in the Division of Infectious Diseases at Washington University, appeared on our first episode of Show Me the Science. One year later, he says we re getting close to returning to normal. But he also says we should think not so much about returning to the old normal as moving toward a new normal that may sometimes include screenings at work to make sure you re not sick, or perhaps smaller gatherings during cold and flu season.
A new episode of our podcast, “Show Me the Science,” has been posted. At present, these podcast episodes are highlighting research and patient care on the Washington University Medical Campus as our scientists and clinicians confront the COVID-19 pandemic.
Giving chemotherapy in the morning rather than the evening could add a few months to patient survival, a new study shows.
Glioblastoma is an aggressive type of brain cancer with no cure. Patients survive an average of 15 months after diagnosis, with fewer than 10% of patients surviving longer than five years.
Average overall survival for all patients in the study, which appears in
Neuro-Oncology Advances, was about 15 months after diagnosis. Those receiving the chemotherapy drug temozolomide in the morning had an average overall survival of about 17 months post diagnosis, compared with an average overall survival of about 13½ months for those taking the drug in the evening, a statistically significant difference of about 3½ months.
New research on Alzheimer’s Disease shows ‘lifestyle origin at least in some degree’ Todd Hollingshead | Apr 2, 2021
Share this:
For years, research to pin down the underlying cause of Alzheimer’s Disease has been focused on plaque found to be building up in the brain in AD patients. But treatments targeted at breaking down that buildup have been ineffective in restoring cognitive function, suggesting that the buildup may be a side effect of AD and not the cause itself.
A new study from a team of BYU researchers finds novel cellular-level support for an alternate theory that is growing in strength: Alzheimer’s could actually be a result of metabolic dysfunction in the brain. In other words, there is growing evidence that diet and lifestyle are at the heart of Alzheimer’s Disease.
Mice experiencing hallucination-like events provide clues to understand psychosis
The humble lab mouse has provided invaluable clues to understanding diseases ranging from cancer to diabetes to COVID-19. But when it comes to psychiatric conditions, the lab mouse has been sidelined, its rodent mind considered too different from that of humans to provide much insight into mental illness.
A new study, however, shows there are important links between human and mouse minds in how they function -; and malfunction. Researchers at Washington University School of Medicine in St. Louis devised a rigorous approach to study how hallucinations are produced in the brain, providing a promising entry point to the development of much-needed new therapies for schizophrenia.